Psychosis breakthrough on antipsychotic maintenance medication (BAMM): what can we learn?
NPJ Schizophr
.
2017 Oct 11;3(1):36.
doi: 10.1038/s41537-017-0039-z.
Authors
Jose M Rubio
1
2
3
,
John M Kane
4
5
6
Affiliations
1
The Zucker Hillside Hospital, Psychiatry Research, Northwell Health, Glen Oaks, NY, USA. jrubio13@northwell.edu.
2
Hofstra Northwell School of Medicine, Hempstead, NY, USA. jrubio13@northwell.edu.
3
The Feinstein Institute for Medical Research, Manhasset, NY, USA. jrubio13@northwell.edu.
4
The Zucker Hillside Hospital, Psychiatry Research, Northwell Health, Glen Oaks, NY, USA.
5
Hofstra Northwell School of Medicine, Hempstead, NY, USA.
6
The Feinstein Institute for Medical Research, Manhasset, NY, USA.
PMID:
29021565
PMCID:
PMC5636818
DOI:
10.1038/s41537-017-0039-z
No abstract available
Publication types
Editorial